Mark Findlay

610 total citations
20 papers, 358 citations indexed

About

Mark Findlay is a scholar working on Nephrology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Findlay has authored 20 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Nephrology, 7 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Findlay's work include Dialysis and Renal Disease Management (7 papers), Acute Ischemic Stroke Management (6 papers) and Renal and Vascular Pathologies (3 papers). Mark Findlay is often cited by papers focused on Dialysis and Renal Disease Management (7 papers), Acute Ischemic Stroke Management (6 papers) and Renal and Vascular Pathologies (3 papers). Mark Findlay collaborates with scholars based in United Kingdom, Singapore and Canada. Mark Findlay's co-authors include Patrick B. Mark, Jesse Dawson, Terence J. Quinn, David Alexander Dickie, Kirsten Forbes, Deborah McGlynn, Alan G. Jardine, Colin Geddes, Wendy Metcalfe and Jamie P. Traynor and has published in prestigious journals such as Stroke, Journal of the American Society of Nephrology and Nephrology Dialysis Transplantation.

In The Last Decade

Mark Findlay

19 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Findlay United Kingdom 9 188 89 84 57 49 20 358
Zhikai Yang China 13 329 1.8× 65 0.7× 31 0.4× 42 0.7× 51 1.0× 39 452
Dawn F. Wolfgram United States 9 233 1.2× 31 0.3× 59 0.7× 49 0.9× 33 0.7× 18 317
Suresh C. Dash India 12 220 1.2× 55 0.6× 107 1.3× 20 0.4× 51 1.0× 19 389
Dijana Jovanović Serbia 12 272 1.4× 52 0.6× 61 0.7× 30 0.5× 96 2.0× 51 470
Rüya Mutluay Türkiye 11 171 0.9× 64 0.7× 49 0.6× 21 0.4× 42 0.9× 30 330
Mary Hannan United States 9 175 0.9× 105 1.2× 37 0.4× 32 0.6× 31 0.6× 27 351
Yelena Slinin United States 9 405 2.2× 138 1.6× 31 0.4× 37 0.6× 85 1.7× 13 525
Björn Runesson Sweden 9 152 0.8× 63 0.7× 31 0.4× 31 0.5× 52 1.1× 14 299
Hiren P. Patel United States 16 282 1.5× 148 1.7× 56 0.7× 22 0.4× 67 1.4× 44 613
Robert K. Riezebos Netherlands 11 61 0.3× 221 2.5× 69 0.8× 34 0.6× 49 1.0× 61 440

Countries citing papers authored by Mark Findlay

Since Specialization
Citations

This map shows the geographic impact of Mark Findlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Findlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Findlay more than expected).

Fields of papers citing papers by Mark Findlay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Findlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Findlay. The network helps show where Mark Findlay may publish in the future.

Co-authorship network of co-authors of Mark Findlay

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Findlay. A scholar is included among the top collaborators of Mark Findlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Findlay. Mark Findlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bell, Samira, Katharine Buck, Edward J Carr, et al.. (2022). The impact of Omicron on outcomes following infection with SARS-CoV-2 in patients with kidney failure in Scotland. Clinical Kidney Journal. 16(1). 197–200. 4 indexed citations
2.
Findlay, Mark, et al.. (2022). Hypercalcaemia and acute kidney injury: A rare presentation of seminoma. The Journal of the Royal College of Physicians of Edinburgh. 52(2). 138–141.
3.
Quinn, Terence J., et al.. (2021). “Is It Removed During Dialysis?”—Cognitive Dysfunction in Advanced Kidney Failure—A Review Article. Frontiers in Neurology. 12. 787370–787370. 22 indexed citations
4.
Findlay, Mark, et al.. (2020). Clinical Companion in Nephrology. 1 indexed citations
5.
Bell, Samira, Jackie McDonald, Katharine Buck, et al.. (2020). COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry. BMC Nephrology. 21(1). 419–419. 21 indexed citations
6.
Findlay, Mark, et al.. (2020). COVID-19 Vaccine Research, Development, Regulation and Access. SSRN Electronic Journal. 1 indexed citations
7.
Findlay, Mark, Rachael MacIsaac, Mary Joan MacLeod, et al.. (2019). The Association of Atrial Fibrillation and Ischemic Stroke in Patients on Hemodialysis: A Competing Risk Analysis. Canadian Journal of Kidney Health and Disease. 6. 2247757887–2247757887. 8 indexed citations
8.
Findlay, Mark, Jesse Dawson, Rachael MacIsaac, et al.. (2018). Inequality in Care and Differences in Outcome Following Stroke in People With ESRD. Kidney International Reports. 3(5). 1064–1076. 14 indexed citations
9.
Lees, Jennifer S., Mark Findlay, Patrick B. Mark, & Colin Geddes. (2018). The impact of coronary angiography on renal transplant function. QJM. 112(1). 23–27. 3 indexed citations
10.
Findlay, Mark, Jesse Dawson, David Alexander Dickie, et al.. (2018). FP520THE FUNCTIONAL AND STRUCTURAL EFFECTS OF END STAGE RENAL DISEASE ON THE BRAIN OVER A 12 MONTH PERIOD. Nephrology Dialysis Transplantation. 33(suppl_1). i214–i214. 2 indexed citations
11.
Findlay, Mark, Jesse Dawson, David Alexander Dickie, et al.. (2018). Investigating the Relationship between Cerebral Blood Flow and Cognitive Function in Hemodialysis Patients. Journal of the American Society of Nephrology. 30(1). 147–158. 128 indexed citations
12.
Findlay, Mark, Rachael MacIsaac, Mary Joan MacLeod, et al.. (2017). Renal replacement modality and stroke risk in end-stage renal disease—a national registry study. Nephrology Dialysis Transplantation. 33(9). 1564–1571. 15 indexed citations
13.
Findlay, Mark, Ken Donaldson, J. G. Fox, et al.. (2016). Factors influencing withdrawal from dialysis: a national registry study. Nephrology Dialysis Transplantation. 31(12). 2041–2048. 35 indexed citations
14.
Findlay, Mark, Peter Thomson, Rachael MacIsaac, et al.. (2016). Risk factors and outcome of stroke in renal transplant recipients. Clinical Transplantation. 30(8). 918–924. 18 indexed citations
15.
Solbu, Marit D., Peter C. Thomson, Mark Findlay, et al.. (2015). Serum phosphate and social deprivation independently predict all-cause mortality in chronic kidney disease. BMC Nephrology. 16(1). 194–194. 11 indexed citations
16.
Findlay, Mark, Peter Thomson, Rachael L. Fulton, et al.. (2015). Risk Factors of Ischemic Stroke and Subsequent Outcome in Patients Receiving Hemodialysis. Stroke. 46(9). 2477–2481. 51 indexed citations
17.
Findlay, Mark & Christopher Isles. (2015). Clinical Companion in Nephrology. Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)). 2 indexed citations
18.
Findlay, Mark, et al.. (2014). Chronic kidney disease rather than illness severity predicts medium- to long-term mortality and renal outcome after acute kidney injury. Nephrology Dialysis Transplantation. 30(4). 594–598. 8 indexed citations
19.
Findlay, Mark, et al.. (2012). Treatment of vitamin D deficiency: divergence between clinical practice and expert advice. Postgraduate Medical Journal. 88(1039). 255–260. 8 indexed citations
20.
Smith, James R., Mark Findlay, Colin Geddes, & J. G. Fox. (2012). The role of sodium thiosulphate in the treatment of calciphylaxis. Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT). 26(4). 245–254. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhikai Yang Breakdown of academic impact, for papers by Dawn F. Wolfgram Breakdown of academic impact, for papers by Suresh C. Dash Breakdown of academic impact, for papers by Dijana Jovanović Breakdown of academic impact, for papers by Rüya Mutluay Breakdown of academic impact, for papers by Mary Hannan Breakdown of academic impact, for papers by Yelena Slinin Breakdown of academic impact, for papers by Björn Runesson Breakdown of academic impact, for papers by Hiren P. Patel Breakdown of academic impact, for papers by Robert K. Riezebos
Rankless by CCL
2026